ArticleProm-1 (Cd 133) Overexpression in Adult Acute Lymphoblastic Leukemia Egyptian Patients and Relation to Outcome
ArticleProm-1 (Cd 133) Overexpression in Adult Acute Lymphoblastic Leukemia Egyptian Patients and Relation to Outcome
ArticleEvaluation of ADAM28 expression in adult Egyptian Acute Myeloid Leukemia patients and its impact on outcome
ArticleEvaluation of ADAM28 expression in adult Egyptian Acute Myeloid Leukemia patients and its impact on outcome
ArticleT- Acute lymphoblastic leukemia: Does our understanding of molecular pathogenesis will impact future treatment?
ArticleT- Acute lymphoblastic leukemia: Does our understanding of molecular pathogenesis will impact future treatment?
ArticleAcute Lymphoblastic Leukemia with Central Nervous System Relapse: Case series of unusual presentation
ArticleAcute Lymphoblastic Leukemia with Central Nervous System Relapse: Case series of unusual presentation
ArticleThe Outcome of Acute Lymphoblastic Leukemia in Infants at National Cancer Institute Egypt: 10 Years Experience
ArticleThe Outcome of Acute Lymphoblastic Leukemia in Infants at National Cancer Institute Egypt: 10 Years Experience
ArticleClinical Features and Treatment Outcome of Pediatric Lymphoblastic Lymphoma at South Egypt Cancer Institute
ArticleClinical Features and Treatment Outcome of Pediatric Lymphoblastic Lymphoma at South Egypt Cancer Institute
ArticleClinicolaboratory Characteristics and Outcome of Pediatric Acute Lymphoblastic Leukemia in a Resource-Limited Setting: A Study from South Egypt
ArticleClinicolaboratory Characteristics and Outcome of Pediatric Acute Lymphoblastic Leukemia in a Resource-Limited Setting: A Study from South Egypt
ArticleExpression of aberrant markers in acute leukemia at South Egypt Cancer Institute: A retrospective study
ArticleExpression of aberrant markers in acute leukemia at South Egypt Cancer Institute: A retrospective study